Cargando…
Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology
INTRODUCTION: Collaborative interactions between several diverse biological processes govern the onset and progression of breast cancer. These processes include alterations in cellular metabolism, anti-tumor immune responses, DNA damage repair, proliferation, anti-apoptotic signals, autophagy, epith...
Autores principales: | Di Sante, Gabriele, Pagé, Jessica, Jiao, Xuanmao, Nawab, Omar, Cristofanilli, Massimo, Skordalakes, Emmanuel, Pestell, Richard G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834352/ https://www.ncbi.nlm.nih.gov/pubmed/31219365 http://dx.doi.org/10.1080/14737140.2019.1615889 |
Ejemplares similares
-
Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation
por: Chen, Ke, et al.
Publicado: (2020) -
Cyclin D1 integrates G9a-mediated histone methylation
por: Li, Zhiping, et al.
Publicado: (2019) -
Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015) -
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
por: Pestell, Timothy G., et al.
Publicado: (2017) -
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
por: Di Sante, Gabriele, et al.
Publicado: (2017)